Combined deletion of mouse dematin-headpiece and beta-adducin exerts a novel effect on the spectrin-actin junctions leading to erythrocyte fragility and hemolytic anemia.
Dematin and adducin are actin-binding proteins of the erythrocyte "junctional complex." Individually, they exert modest effects on erythrocyte shape and membrane stability, and their homologues are expressed widely in non-erythroid cells. Here we report generation and characterization of double knock-out mice lacking beta-adducin and the headpiece domain of dematin. The combined mutations result in altered erythrocyte morphology, increased membrane instability, and severe hemolysis. Peripheral blood analysis shows evidence of severe hemolytic anemia with reduced number of erythrocytes/hematocrit/hemoglobin and an approximately 12-fold increase in the number of circulating reticulocytes. The presence of a variety of misshapen and fragmented erythrocytes correlates with increased osmotic fragility and reduced in vivo life span. Despite the apparently normal protein composition of the mutant erythrocyte membrane, the retention of the spectrin-actin complex in the membrane under low ionic strength conditions is significantly reduced by the double mutation. Atomic force microscopy reveals an increase in grain size and a decrease in filament number of the mutant membrane cytoskeleton, although the volume parameter is similar to wild type erythrocytes. Aggregated, disassembled, and irregular features are visualized in the mutant membrane, consistent with the presence of large protein aggregates. Importantly, purified dematin binds to the stripped inside-out vesicles in a saturable manner, and dematin-membrane binding is abolished upon pretreatment of membrane vesicles with trypsin. Together, these results reveal an essential role of dematin and adducin in the maintenance of erythrocyte shape and membrane stability, and they suggest that the dematin-membrane interaction could link the junctional complex to the plasma membrane in erythroid cells.
Chen
Huiqing
H
Department of Pharmacology/Cancer Center, University of Illinois College of Medicine, Chicago, Illinois 60612, USA.
Khan
Anwar A
AA
Liu
Fei
F
Gilligan
Diana M
DM
Peters
Luanne L
LL
Messick
Joanne
J
Haschek-Hock
Wanda M
WM
Li
Xuerong
X
Ostafin
Agnes E
AE
Chishti
Athar H
AH
D000199:Actins / Q000378:metabolism* / Q000502:physiology; D000743:Anemia, Hemolytic / Q000097:blood* / Q000235:genetics; D000818:Animals; D001798:Blood Proteins / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D002148:Calmodulin-Binding Proteins / Q000097:blood / Q000172:deficiency / Q000235:genetics*; D003598:Cytoskeletal Proteins; D004195:Disease Models, Animal; D004910:Erythrocyte Membrane / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D017353:Gene Deletion; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D018625:Microscopy, Atomic Force; D009996:Osmotic Fragility / Q000235:genetics*; D010750:Phosphoproteins / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D013049:Spectrin / Q000378:metabolism* / Q000502:physiology; D000099291:Adducins
D000199:Actins; D001798:Blood Proteins; D002148:Calmodulin-Binding Proteins; D003598:Cytoskeletal Proteins; D010750:Phosphoproteins; D013049:Spectrin; D000099291:Adducins; C489041:Dmtn protein, mouse